Difficult Decisions in Endocrine Surgery pp 193-208 | Cite as
Lymph Node Dissection Versus No Lymph Node Dissection for Parathyroid Cancer
Abstract
Surgery is the primary treatment for parathyroid carcinoma, but no consensus statement exists regarding the optimal extent of the initial resection. Given the rare nature of the disease, the literature is almost entirely limited to retrospective reviews, but was used in an attempt to determine the impact a routine central neck dissection has on recurrence, survival, and complications in patients being treated for parathyroid carcinoma. Nodal metastases do seem to predict recurrence but not worse survival. However, no clear difference was observed in recurrence or survival based on whether or not a lymph node dissection was performed indicating that there is minimal value in a nodal dissection as a routine procedure in all patients. While the addition of a central neck dissection does not increase rates of vocal cord palsies or hematomas, it does carry a significant risk of permanent hypoparathyroidism. Therefore, because there is no definitive benefit in patients with parathyroid carcinoma, the added risk of a routine central node dissection is not justified for all patients.
Keywords
Parathyroid cancer Central compartment lymph node dissection Lymph node metastases Parathyroidectomy Neck explorationReferences
- 1.Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109(9):1736–41.CrossRefPubMedGoogle Scholar
- 2.Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on cancer and the American Cancer Society. Cancer. 1999;86(3):538–44.CrossRefPubMedGoogle Scholar
- 3.Villar-Del-Moral J, Jimenez-Garcia A, Salvador-Egea P, Martos-Martinez JM, Nuno-Vazquez-Garza JM, Serradilla-Martin M, et al. Prognostic factors and staging systems in parathyroid cancer: a multicenter cohort study. Surgery. 2014;156(5):1132–44.CrossRefPubMedGoogle Scholar
- 4.Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132(3):359–72.CrossRefPubMedGoogle Scholar
- 5.Iihara M, Okamoto T, Suzuki R, Kawamata A, Nishikawa T, Kobayashi M, et al. Functional parathyroid carcinoma: long-term treatment outcome and risk factor analysis. Surgery. 2007;142(6):936–43.CrossRefPubMedGoogle Scholar
- 6.Wang CA, Gaz RD. Natural history of parathyroid carcinoma. Diagnosis, treatment, and results. Am J Surg. 1985;149(4):522–7.CrossRefPubMedGoogle Scholar
- 7.Agarwal G, Prasad KK, Kar DK, Krishnani N, Pandey R, Mishra SK. Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology. World J Surg. 2006;30(5):732–42.CrossRefPubMedGoogle Scholar
- 8.Ippolito G, Palazzo FF, Sebag F, De MC, Henry JF. Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg. 2007;94(5):566–70.CrossRefPubMedGoogle Scholar
- 9.Cohn K, Silverman M, Corrado J, Sedgewick C. Parathyroid carcinoma: the Lahey clinic experience. Surgery. 1985;98(6):1095–100.PubMedGoogle Scholar
- 10.Pelizzo MR, Piotto A, Bergamasco A, Rubello D, Casara D. Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience. Minerva Endocrinol. 2001;26(1):23–9.PubMedGoogle Scholar
- 11.Trigonis C, Cedermark B, Willems J, Hamberger B, Granberg PO. Parathyroid carcinoma--problems in diagnosis and treatment. Clin Oncol. 1984;10(1):11–9.PubMedGoogle Scholar
- 12.Smith JF, Coombs RR. Histological diagnosis of carcinoma of the parathyroid gland. J Clin Pathol. 1984;37(12):1370–8.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.McKeown PP, McGarity WC, Sewell CW. Carcinoma of the parathyroid gland: is it overdiagnosed?A report of three cases. Am J Surg. 1984;147(2):292–8.CrossRefPubMedGoogle Scholar
- 14.Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15(6):738–44.CrossRefPubMedGoogle Scholar
- 15.Wynne AG, van HJ, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71(4):197–205.CrossRefGoogle Scholar
- 16.Lee YS, Hong SW, Jeong JJ, Nam KH, Chung WY, Chang HS, et al. Parathyroid carcinoma: a 16-year experience in a single institution. Endocr J. 2010;57(6):493–7.CrossRefPubMedGoogle Scholar
- 17.Favia G, Lumachi F, Polistina F, D’Amico DF. Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg. 1998;22(12):1225–30.CrossRefPubMedGoogle Scholar
- 18.Chandar AK, Falck-Ytter Y. Evidence based medicine: quality of evidence and evaluation systems. In: Ferguson MK, editor. Difficult decisions in thoracic surgery, difficult decisions in surgery: an evidence-based approach 1. 3rd ed. London: Springer; 2014. p. 17–33.Google Scholar
- 19.Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, Ordonez NG, Hickey RC. Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery. 1983;94(6):906–15.PubMedGoogle Scholar
- 20.Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26(8):716–26.CrossRefPubMedGoogle Scholar
- 21.Hakaim AG, Esselstyn CB Jr. Parathyroid carcinoma: 50-year experience at the Cleveland Clinic Foundation. Cleve Clin J Med. 1993;60(4):331–5.CrossRefPubMedGoogle Scholar
- 22.Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136(8):878–85.CrossRefPubMedGoogle Scholar
- 23.Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol. 1999;8(3):155–65.CrossRefPubMedGoogle Scholar
- 24.Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96(12):3679–86.CrossRefPubMedGoogle Scholar
- 25.Hsu KT, Sippel RS, Chen H, Schneider DF. Is central lymph node dissection necessary for parathyroid carcinoma? Surgery. 2014;156(6):1336–41.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Sadler C, Gow KW, Beierle EA, Doski JJ, Langer M, Nuchtern JG, et al. Parathyroid carcinoma in more than 1,000 patients: a population-level analysis. Surgery. 2014;156(6):1622–30.CrossRefPubMedGoogle Scholar
- 27.Holmes EC, Morton DL, Ketcham AS. Parathyroid carcinoma: a collective review. Ann Surg. 1969;169(4):631–40.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Cordeiro AC, Montenegro FL, Kulcsar MA, Dellanegra LA, Tavares MR, Michaluart P Jr, et al. Parathyroid carcinoma. Am J Surg. 1998;175(1):52–5.CrossRefPubMedGoogle Scholar
- 29.Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16(4):724–31.CrossRefPubMedGoogle Scholar
- 30.Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004;100(5):900–5.CrossRefPubMedGoogle Scholar
- 31.Talat N, Schulte KM. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol. 2010;17(8):2156–74.CrossRefPubMedGoogle Scholar
- 32.Schulte KM, Talat N, Miell J, Moniz C, Sinha P, Diaz-Cano S. Lymph node involvement and surgical approach in parathyroid cancer. World J Surg. 2010;34(11):2611–20.CrossRefPubMedGoogle Scholar
- 33.Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31(3):600–5.CrossRefPubMedGoogle Scholar
- 34.Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86(3):378–80.CrossRefPubMedGoogle Scholar
- 35.Owen RP, Silver CE, Pellitteri PK, Shaha AR, Devaney KO, Werner JA, et al. Parathyroid carcinoma: a review. Head Neck. 2011;33(3):429–36.PubMedGoogle Scholar
- 36.Fernandez-Ranvier GG, Khanafshar E, Jensen K, Zarnegar R, Lee J, Kebebew E, et al. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer. 2007;110(2):255–64.CrossRefPubMedGoogle Scholar
- 37.Bae JH, Choi HJ, Lee Y, Moon MK, Park YJ, Shin CS, et al. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism. J Korean Med Sci. 2012;27(8):890–5.CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Schulte KM, Gill AJ, Barczynski M, Karakas E, Miyauchi A, Knoefel WT, et al. Classification of parathyroid cancer. Ann Surg Oncol. 2012;19(8):2620–8.CrossRefPubMedGoogle Scholar
- 39.LiVolsi VA, Hamilton R. Intraoperative assessment of parathyroid gland pathology. A common view from the surgeon and the pathologist. Am J Clin Pathol. 1994;102(3):365–73.CrossRefPubMedGoogle Scholar
- 40.Kwan WY, Chow TL, Choi CY, Lam SH. Complication rates of central compartment dissection in papillary thyroid cancer. ANZ J Surg. 2013;85(4):274–8.CrossRefPubMedGoogle Scholar
- 41.Sadowski BM, Snyder SK, Lairmore TC. Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery. 2009;146(4):696–703.CrossRefPubMedGoogle Scholar
- 42.So YK, Seo MY, Son YI. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. Surgery. 2012;151(2):192–8.CrossRefPubMedGoogle Scholar
- 43.Palestini N, Borasi A, Cestino L, Freddi M, Odasso C, Robecchi A. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbeck’s Arch Surg. 2008;393(5):693–8.CrossRefGoogle Scholar
- 44.Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015;100(4):1316–24. https://doi.org/10.1210/jc.2014-3825.CrossRefPubMedGoogle Scholar
- 45.Alvarado R, Sywak MS, Delbridge L, Sidhu SB. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: is there added morbidity? Surgery. 2009;145(5):514–8.CrossRefPubMedGoogle Scholar